https://www.selleckchem.com/products/art558.html
PMI-Au SNH in vivo suppressed tumor growth potently after three administrations intravenous injection, intraperitoneal injection and gastric perfusion, and maintained a favorable therapeutic safety. Conclusion This therapeutically feasible strategy of peptide nanoengineering will allow us to fabricate a series of nanomedicines to modulate carcinogenic PPIs that hide and multiply inside cells, and in all likelihood reinvigorate the development of peptide drug against wide varieties of human diseases.Enhancer of Zeste Homolog 2 (EZH2), a k
Like
Comment
Share
